ASIF420 fuels cannabis ventures all over the world and take pride in fostering entrepreneurship everywhere. We joined forces with key global leaders to create a unique international platform for the development of cannabinoid-based products. Leveraging Israel’s advanced cannabis development ecosystem to become one of a kind ‘seed to shelf’ business partner.
ASIF420 was founded in 2018 to fulfil one goal: To find great ideas and transform them into successful companies for our investors. Everything we have done—from the culture we have nurtured, the funds we have created and the platform we have built—has been in support of that singular goal.
ASIF420 provides deep strategic network of business and marketing experts to help build cannabis-oriented market-leading companies worldwide. Being at the forefront of digital disruption benefits the network synergies and knowledge share of regional groups in various functional areas.
Based on the ASIF420 Legal Index Report 2020
Technological models enable us to make informed, data-driven decisions and deep analysis. These decisions affect our growth targets, product quantities and investment vehicles that will serve as future engines of growth, creating leadership and competitive differentiation.
We are a research-oriented company that uses technological models that enable leadership and innovation in research. Through them, the medicinal benefits of the cannabis plant can be maximised – with specific solutions for Chronic pain patients, Depression syndromes and other neurological diseases.
This approach enables us to create solutions to problems that arise from the field, to implement and test their effectiveness and to make repairs quickly and efficiently, enabling us to identify viable business opportunities with maximum impact and reduce the time gaps in reaching the market.
A special task requires special people. We had assemble our leading planning and execution expert team from all fields of activity: agriculture, formulation, analysis, regulation, law, commerce, logistics, research, genetics and information technology in order to complete each venture.
As new business verticals emerge into the global cannabis landscape, our business models remain data driven and ROI oriented throughout the life cycle of each venture.
We ignore ‘keep’ or ‘sell’ decision to avoid defocus. This position allows us to exit at high value in more mature markets and remain Evergreen by spearheading in emerging industries we identify as potentially scalable.